DNMT3A‐mediated silencing of PDLIM4 is an early epigenetic event that facilitates CRC progression and the potential of PDLIM4 methylation as a non‐invasive CRC biomarker is supported.
Jia-Xin Wang, Chuan-Guo Guo, L. Qi et al.· Clinical and Translational M...· 0 citations
To systematically evaluate the efficacy, safety, and optimal administration parameters (dosage, treatment duration, regimen type, and publication era of the articles) of Saccharomyces boulardii as an adjunct therapy to Helicobacter pylori eradication therapy.
Hong-Kai Chang, Lu-Bo Shi, Hui-Xin Song et al.· Journal of Digestive Disease...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.